glutathione and triple negative breast cancer Role of in Cancer: From Mechanisms to Therapies A review of biological targets
A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect Dual metabolic targeting liposomes potentiate triple negative breast cancer radiosensitivity via glucose and glutathione starvation ScienceDirect Glutathione depleting self immolative nanoparticles boost cuproptosis driven metalloimmunotherapy for triple negative breast cancer Journal of Nanobiotechnology Springer Nature Link Frontiers Ferroptosis: the emerging player in remodeling triple negative breast cancer GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect
Pay in 4 interest-free payments of $6.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13





